Research programme: hepatitis C virus NS5B polymerase inhibitors - IRBMAlternative Names: HCV NS5B inhibitors - IRBM
Latest Information Update: 24 Mar 2010
At a glance
- Originator Istituto di Ricerche di Biologia Molecolare
- Class Indoles; Small molecules
- Mechanism of Action Hepatitis C virus NS 5 protein inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Hepatitis C